We have conducted the ROC analysis to assess the diagnostic performance of both serum sclerostin and CIMT in detecting DN in children and adolescents with T1DM (n = 50), divided into those with DN (n = 25) and without DN (n = 25), where healthy controls were not included. This evidence concerns the gene SOST and liver dysplastic nodule.